Ignite Creation Date:
2024-05-06 @ 6:53 PM
Last Modification Date:
2024-10-26 @ 2:57 PM
Study NCT ID:
NCT05827081
Status:
SUSPENDED
Last Update Posted:
2024-04-24
First Post:
2023-04-12
Brief Title:
Phase IIIb Study of Ribociclib ET in Early Breast Cancer
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis